5-lipoxygenase as an endogenous modulator of amyloid beta formation in vivo

Annals of Neurology

Volumn 69, Issue 1, 2011, Pages 34-46

  Chu, Jin ^a   Praticò, Domenico ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYICOSATETRAENOIC ACID; ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; ARACHIDONATE 5 LIPOXYGENASE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOCEBENONE; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; L 685458; MESSENGER RNA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG SELECTIVITY; ENZYME REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; CENTRAL NERVOUS SYSTEM; CHEMOTACTIC FACTORS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ENZYME ACTIVATION; FEMALE; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; IMMUNOBLOTTING; LEUKOTRIENES; LINOLEIC ACIDS; LIPOXYGENASE INHIBITORS; MICE; MUTATION; NEUROBLASTOMA; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 79551473183     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22234     Document Type: Article

References (30)

1. Rådmark O, Werz O, Steinhilber D, Samuelsson B., 5-Lipoxygenase: regulation of expression and enzyme activity. Trends Biochem Sci 2007; 32: 332-341.
2. Mehrabian M, Allayee H., 5-lipoxygenase and atherosclerosis. Curr Opin Lipidol 2003; 14: 447-457.
3. Uz T, Pesold C, Longone P, Manev H., Age-associated up-regulation of neuronal 5-lipoxygenase expression: putative role in neuronal vulnerability. FASEB J 1998; 12: 439-449.
4. Chinnici CM, Yao Y, Praticò D., The 5-lipoxygenase enzymatic pathway in the mouse brain: young versus old. Neurobiol Aging 2007; 28: 1457-1462.
5. Praticò D., Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. Trends Pharmacol Sci 2008; 29: 609-615.
6. Firuzi O, Zhuo J, Chinnici CM, et al. 5-Lipoxygenase gene disruption reduces amyloid-β pathology in a mouse model of Alzheimer's disease. FASEB J 2008; 22: 1169-1178.
7. Succol F, Praticò D., A role for 12/15 lipoxygenase in the amyloid β precursor protein metabolism. J Neurochem 2007; 103: 380-387.
8. Sung S, Yang H, Uryu K, et al. Modulation of nuclear factor-B activity by indomethacin influences Aβ levels but not Aβ precursor protein metabolism in a model of Alzheimer's disease. Am J Pathol 2004; 165: 2197-2206.
9. Shineman DW, Zhang B, Leight SN, et al. Thromboxane receptor activation mediates isoprostane-induced increases in amyloid pathology in Tg2576 mice. J Neurosci 2008; 28: 4785-4794.
10. Josien H., Recent advances in the development of γ-secretase inhibitors. Curr Opin Drug Discov Devel 2002; 5: 513-525.
11. Netzer WJ, Dou F, Cai D, et al. Gleevec inhibits β-amyloid production but not Notch cleavage. Proc Natl Acad Sci U S A 2003; 100: 12444-12449.
12. -ΔΔCT method. Method 2002; 25: 402-408.
13. Paige M, Saprito MS, Bunyan DA, Shim YM., HPLC quantification of 5-hydroxyeicosatetraenoic acid in human lung cancer tissues. Biomed Chromatogr 2009; 23: 817-821.
14. Praticò D, Zhukareva V, Yao Y, et al. 12/15-lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress. Am J Pathol 2004; 164: 1655-1662.
15. Riccioni G, DiIlio C, Conti P, et al. Advances in therapy with anti-leukotriene drugs. Ann Clin Lab Sci 2004; 34: 379-387.
16. Geling A, Steiner H, Willem M, et al. A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO Rep 2002; 3: 688-694.
17. Dronadula N, Rizvi F, Blaskova E, et al. Involvement of cAMP response element binding protein-1 in arachidonic-induced vascular smooth muscle cell motility. J Lipid Res 2006; 47: 767-777.
18. Sands WA, Palmer TM., Regulating gene transcription in response to cyclic AMP elevation. Cell Signaling 2008; 20: 460-466.
19. Ikonomovic MD, Abrahamson EE, Uz T, et al. Increased 5-lipooxygenase immunoreactivity in hippocampus of patients with Alzheimer's diseases. J Histochem Cytochem 2008; 56: 1065-1073.
20. Qu T, Manev R, Manev H., 5-Lipoxygenase (5-LOX) promoter polymorphism in patients with early-onset and late-onset Alzheimer's disease. J Neuropsychiatry Clin Neurosci 2001; 13: 304-305.
21. Hardy J, Selkoe DJ., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297: 353-356.
22. Wolfe MS., Inhibition and modulation of gamma-secretase for Alzheimer's disease. Neurotherapeutics 2008; 5: 391-398.
23. Luo WJ, Wang H, Li H, et al. PEN-2 and APH-1 coordinately regulate proteolytic processing of presenilin 1. J Biol Chem 2003; 278: 7850-7854.
24. Wang R, Zhang YW, Sun P, et al. Transcriptional regulation of Pen-2, a key component of the γ-secretase complex, by CREB. Mol Cell Biol 2006; 26: 1347-1354.
25. Pastorcic M, Das HK., Alternative initiation of transcription of the human presenilin 1 gene in SH-SY5Y and SK-N-SH cells. The role of Ets factors in the regulation of presenilin 1. Eur J Biochem 2004; 271: 4485-4494.
26. Wen Y, Yu WH, Maloney B, et al. Transcriptional regulation of β-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron 2008; 57: 680-690.
27. Christensen MA, Zhou W, Qing H, et al. Transcriptional regulation of BACE-1, the β-amyloid precursor protein β secretase, by Sp1. Mol Cell Biol 2004; 24: 865-874.
28. De Strooper B, Annaert W, Cupers P, et al. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 1999; 398: 518-522.
29. Marambaud P, Shioi J, Serban G, et al. A presenilin-1/γ-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J 2002; 21: 1948-1956.
30. Qin W, Ho L, Pompl PN, et al. Cyclooxygenase (COX)-2 and COX-1 potentiate beta-amyloid peptide generation through mechanisms that involve gamma-secretase activity. J Biol Chem 2003; 278: 50970-50977.